Ethical issues surrounding the evaluation of oxidative phosphorylation disorders in children
1Emory University School of Medicine, Scottish Rite Molecular Medicine Laboratory, Children's Healthcare of Atlanta, Atlanta, Georgia 30342-1600, USA.
Insights
Genetic testing for pediatric neurological issues is rising. Ethical considerations for oxidative phosphorylation disorders involve informed consent, patient autonomy, and genetic privacy.
Area of Science:
- Pediatric Genetics
- Mitochondrial Diseases
- Bioethics
Background:
- Genetic testing is increasingly used in pediatric evaluations.
- Oxidative phosphorylation disorders are a growing consideration for undiagnosed pediatric neurological problems.
- These disorders have complex genetic control involving nuclear and mitochondrial DNA.
Purpose of the Study:
- To explore the ethical issues arising from genetic testing for oxidative phosphorylation disorders in children.
- To emphasize the importance of informed consent, patient autonomy, and family-centered care.
- To address concerns regarding genetic discrimination and privacy laws.
Main Methods:
- Literature review on genetic testing in pediatrics.
- Analysis of ethical frameworks for genetic disorders.
- Case study review of pediatric neurological cases with suspected oxidative phosphorylation disorders.
Main Results:
- Genetic testing complexity necessitates careful ethical navigation.
- Informed consent requires clear communication about dual genetic origins (nuclear and mitochondrial DNA).
- Balancing patient/family interests with diagnostic procedures is crucial.
Conclusions:
- Open communication is paramount in pediatric genetic medicine.
- Ethical challenges in genetic testing require proactive management.
- Upholding patient autonomy and privacy is essential when diagnosing mitochondrial disorders.
Abstract:
Genetic testing is becoming increasingly frequent as a part of a pediatric evaluation. Oxidative phosphorylation disorders are likewise becoming part of the differential diagnosis for many children with undiagnosed neurologic problems. The complexity of the oxidative phosphorylation pathway and its dual genetic control by nuclear and mitochondrial DNA raise a number of ethical issues dealing mainly with the informed consent process, the respect for a patient's autonomy, the best interest of the patients and their families, as well as issues of genetic discrimination and genetic privacy laws. Open communication with families in pediatric medicine remains the cornerstone of good ethics, along with the skill needed to avoid having ethical issues arise.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
14:39Cholinergic Ligand–dependent Modulation of Oxidative Phosphorylation Coupling in Digitonin-permeabilized BE(2)-C Neuroblastoma Cells
Published on: April 28, 2026
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Electron Transport Chain: Complex III and IV
